Journals / Retina-Vitreus / 2021 / Cilt: 30 - Sayı: 2

Short-term Vitreoretinal Tamponade with Perfluorodecalin for Retinal Detachment

Pages
158–162
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: PFD seems to be safe to use as a short-term postoperative vitreoretinal tamponade, and it is useful in retinal detachment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study was to use per fluorodecalin (PFD) as a short-term postoperative vitreoretinal tamponade and evaluate its effectiveness in retinal detachment.
📊
Key Findings & Data:Materials and Methods: This retrospective case series consisted of eight consecutive patients (four female, four male) who presented with retinal detachment (traumatic, secondary to inferior retinal tear, presence of proliferative vitreoretinopathy) at a tertiary u niversity medical center in 2018–2019.
💡
Conclusion & Impact:Conclusion: PFD seems to be safe to use as a short-term postoperative vitreoretinal tamponade, and it is useful in retinal detachment.
🔬Design:Research Article
📍Scope:2018–2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: The aim of this study was to use per fluorodecalin (PFD) as a short-term postoperative vitreoretinal tamponade and evaluate its effectiveness in retinal detachment. Materials and Methods: This retrospective case series consisted of eight consecutive patients (four female, four male) who presented with retinal detachment (traumatic, secondary to inferior retinal tear, presence of proliferative vitreoretinopathy) at a tertiary u niversity medical center in 2018–2019. All patients underwent pars plana vitrectomy with short-term PFD tamponade. Patients with a minimum follow -up of 3 months were included in the study. The medical charts were analyzed for patient demographics, retinal attachment rates, pre- and postoperative visual acuity, and postoperative complications. Results: The mean duration of PFD tamponade was 16.5 ± 6.3 (range, 7–27) days. The mean follow-up time for the patients was 8.63 ± 2.5 months. The retina was reattached intraoperatively in all patients. In seven patients (87.5%), the retina was still attached throughout follow-up without further vitrectomies. A statistically significant increase was observed when preoperative mean best-corrected visual acuity (BCVA) was compared with mean BCVA in the last follow-up visit (2.9 ± 0.3, 1.3 ± 0.7 logMAR respectively, p=0.018). In seven (87.5%) p atients, BCVA improved postoperatively compared with preoperatively. In the postoperative period, pupillary membrane formation was obser ved in two (25.0%) patients, retrolental membrane in one (12.5%) patient, and epiretinal membrane in one (12.5%) patient. Conclusion: PFD seems to be safe to use as a short-term postoperative vitreoretinal tamponade, and it is useful in retinal detachment.

🔖

Cite This Article

ÖZTÜRK, E., GÜNDÜZ, A., ÖZSOY, E., YILDIZLI, Y. (2022). Short-term Vitreoretinal Tamponade with Perfluorodecalin for Retinal Detachment. Retina-Vitreus, Cilt: 30 - Sayı: 2, 158–162. https://ajindex.com/articles/589064

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Figueroa MS, Casas DR. In flammation induced by perfluorocarbon liquid: intra- and postoperative use. Biomed Res Int. 2014;2014:907816
  2. Sargent JW, Sef fl RJ. Properties of per fluorinated liquids. Fed Proc. 1970;29:1699-703
  3. Sparrow JR, Jayakumar A, Berrocal M, et al. Experimental studies of the combined use of vitreous substitutes of high and low specific gravity. Retina. 1992;12:134-40
  4. Chang S. Low viscosity liquid fluorochemicals in vitreous surgery. Am J Ophthalmol. 1987;103:38-43
  5. Eiger-Moscovich M, Gershoni A, Axer-Siegel R, et al. Short- Term Vitreoretinal Tamponade with Heavy Liquid Following Surgery for Giant Retinal Tear. Curr Eye Res. 2017;42:1074-8
  6. Vardanyan AH, Hovakimyan AV, Hambartsumyan AV. Results of surgical treatment of retinal detachments complicated with proliferative vitreoretinopathies with the use of per fluropropane (C3F8) gas. Med Sci Monit. 2000;6:704-7
  7. Zafar S, Bokhari SA, Kamil Z, et al. Outcomes of silicone oil removal. J Coll Physicians Surg Pak. 2013;23:476-9
  8. Drury B, Bourke RD. Short-term intraocular tamponade with perfluorocarbon heavy liquid. Br J Ophthalmol. 2011;95:694-8
  9. Sigler EJ, Randolph JC, Calzada JI, et al. Pars plana vitrectomy with medium-term postoperative per fluoro-N-octane for recurrent inferior retinal detachment complicated by advanced proliferative vitreoretinopathy. Retina. 2013;33:791-7
  10. Rush R, Sheth S, Surka S, et al. Postoperative per fluoro-N- octane tamponade for primary retinal detachment repair. Retina. 2012;32:1114-20
  11. Sigler EJ, Randolph JC, Calzada JI, et al. 25-gauge pars plana vitrectomy with medium-term postoperative per fluoro-n-octane tamponade for inferior retinal detachment. Ophthalmic Surg Lasers Imaging Retina. 2013;44:34-40
  12. Mikhail MA, Mangioris G, Best RM, et al. Management of giant retinal tears with vitrectomy and per fluorocarbon liquid postoperatively as a short-term tamponade. Eye (London, England). 2017;31:1290-5
  13. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90:121-5
  14. Al-Khairi AM, Al-Kahtani E, Kangave D, et al. Prognostic factors associated with outcomes after giant retinal tear management using perfluorocarbon liquids. Eur J Ophthalmol. 2008;18:270-7
  15. Goezinne F, EC LAH, Berendschot TT, et al. Low redetachment rate due to encircling scleral buckle in giant retinal tears treated with vitrectomy and silicone oil. Retina. 2008;28:485-92
  16. Batman C, Cekic O. Vitrec